Search Results 781-790 of 18564 for Relapse
Root Cause of Multiple Myeloma Relapse Revealed. Dana Sparks. September 18, 2013. Cancer. Mayo Clinic Receives $8.8 Million Federal Grant for Metabolomics ...
This phase II trial is studying the side effects and how well cixutumumab works in treating patients with relapsed or refractory solid tumors. Monoclonal ...
... relapsed lymphoma. For nodular lymphocyte-predominant ... You may have repeat blood and imaging tests and, if needed, biopsies, to check for a relapse.
Root Cause of Multiple Myeloma Relapse Revealed. Dana Sparks. September 18, 2013. First · Previous ... 340 · 341 · 342 · 343 · 344 · 345 · 346 ... Next · Last.
They can also increase your risk of getting infected again (relapse). Request an appointment. Self care. Even if you don't need medical attention for your ...
The purpose of this study is to assess the safety and tolerability of escalating intratumoral doses of mRNA-2752 in participants with relapsed/refractory solid ...
AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL. Rochester, Minn. This is a Phase 2 global, multi-center, open-label study ...
NL-201 in Patients With Relapsed or Refractory Cancer. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to ...
... (relapsed) or is not responding to treatment (refractory). ... In particular, the trial will focus on the 100-day non-relapse mortality as an indicator of the ...
Relapse prevention. Dr. Hays says what works is a combination of approaches, including medication, behavioral therapies and relapse prevention strategies. We ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.